InvestorsHub Logo
Followers 24
Posts 1640
Boards Moderated 0
Alias Born 08/08/2012

Re: None

Monday, 03/10/2014 10:28:02 AM

Monday, March 10, 2014 10:28:02 AM

Post# of 158400
My favorite line here....

http://www.smallcapnetwork.com/Three-Jumping-Small-Cap-Biotech-or-Tech-Stocks-ANSU-BMSN-THNS/s/via/21051/article/view/p/mid/1/id/322/

What’s the Catch With Bio Matrix Scientific Group Inc? According to various disclosures, no transactions have occurred to mention the Bio Matrix Scientific Group in various investment newsletters. Last Thursday, Bio-Matrix Scientific Group announced that March 18, 2014 will be the date for determining shareholder eligible to receive a special dividend consisting of a pro rata share of 20,000,000 Regen BioPharma common shares and its anticipated that shareholders of record will receive one share of Regen Biopharma, Inc. for every 147 shares of BMSN (Bio-Matrix Scientific Group will still be a majority owner of Regen BioPharma). Otherwise, it should be noted that last September, Bio Matrix Scientific Group filed a Form 8-K to give notice that “certain items included within the Company's Consolidated Statement of Cash Flows for the year ended September 30, 2012 and for the period from inception to September 30 2012 constituted noncash activities which do not affect Net Income and these items have been eliminated from the Company's Statements of Cash Flows.” A Form 8-K/A was then filed on February 10th with the statements corrected. A look at Bio Matrix Scientific Group’s financials as posted on Yahoo! Finance reveals no revenues; net losses of $914k (most recent reported quarter), $179k, $279k and $941k for the past four reported quarters; and had $269k in cash to cover $1,400k in current liabilities at the end of last December. So maybe investors should wait for more news about the company’s Phase I/ II clinical trials.


JustStartingOut

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.